Evidence map›Paper›PMID 36286314›Full record

ArticleJournal of cardiovascular development and disease2022

Colchicine in Cardiac Surgery: The COCS Randomized Clinical Trial.

Vladimir Shvartz, Tatyana Le, Soslan Enginoev, Maria Sokolskaya, Artak Ispiryan, Elena Shvartz, Daria Nudel, Naylyana Araslanova, Andrey Petrosyan, Sergey Donakanyan and 3 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04224545 phase4completednot on this map

Colchicine for Prevention Atrial Fibrillation After Cardiac Surgery in the Early Postoperative Period

TypeinterventionalSponsorBakulev Scientific Center of Cardiovascular SurgeryRan2019 to 2022Enrolled267ConditionsColchicine Adverse Reaction, Atrial Fibrillation New OnsetArmsColchicine Pill, Placebo
NCT06936709 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of Colchicine in the Perioperative Period on Reducing Post-Operative Pain in Total Knee Arthroplasty

TypeinterventionalSponsorGeisinger ClinicRan2025 to 2026Enrolled75ConditionsOsteoarthritis of Knee, Recovery Following Primary Total Knee Arthroplasty, Perioperative Pain ControlArmsColchicine 1.8 mg (loading dose) + Dextrose Oral Placebo, Colchicine 1.8 mg + 0.6 mg, Dextrose Oral Placebo
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Pooled it
  2. Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  3. Colchicine therapy in transcatheter aortic valve replacement: Modulating inflammation and outcomes.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  4. Review
  5. Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. [Colchicine-Phoenix from the ashes].Wiener klinische Wochenschrift · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vladimir ShvartzBakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.ORCID 0000-0002-8931-0376
Tatyana LeBakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Soslan EnginoevFederal Center for Cardiovascular Surgery of the Russian Federation Ministry of Healthcare (Astrakhan), 414011 Astrakhan, Russia.ORCID 0000-0002-8376-3104
Maria SokolskayaBakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Artak IspiryanBakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Elena ShvartzNational Medical Research Center for Therapy and Preventive Medicine, 101990 Moscow, Russia.ORCID 0000-0002-8638-7327
Daria NudelFederal Center for Cardiovascular Surgery of the Russian Federation Ministry of Healthcare (Astrakhan), 414011 Astrakhan, Russia.
Naylyana AraslanovaFederal Center for Cardiovascular Surgery of the Russian Federation Ministry of Healthcare (Astrakhan), 414011 Astrakhan, Russia.
Andrey PetrosyanBakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Sergey DonakanyanBakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Igor ChernovFederal Center for Cardiovascular Surgery of the Russian Federation Ministry of Healthcare (Astrakhan), 414011 Astrakhan, Russia.
Leo BockeriaBakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Elena GolukhovaBakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.

Funding

Russian Science Foundation 18-74-10064
6 · The paper itself

Abstract

backgroundIn patients who underwent cardiac surgery, first-time postoperative atrial fibrillation (POAF) is associated with increased incidence of hospital-acquired complications and mortality. Systemic inflammation is one of confirmed triggers of its development. The anti-inflammatory properties of colchicine can be effective for the POAF prevention. However, the results of several studies were questionable and required further investigation. Hence, we aimed to evaluate the effectiveness of low-dose short-term colchicine administration for POAF prevention in patients after the open-heart surgery. This double-blind randomized placebo-controlled trial included 267 patients, but 27 of them dropped out in the course of the study. Study subjects received the test drug on the day before the surgery and on postoperative days 2, 3, 4 and 5. The rhythm control was conducted immediately after the operation and until the discharge from the hospital. The final analysis included 240 study subjects: 113 in the colchicine group and 127 in the placebo group. POAF was observed in 21 (18.6%) patients of the colchicine group vs. 39 (30.7%) control patients (OR 0.515; 95% Cl 0.281-0.943;

Indexed as

aortic valve replacementcolchicinecoronary artery bypass graftingpostoperative atrial fibrillation

Identifiers

PMID36286314
PMCPMC9604685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.